P

Inventor

ASHTON MARK RICHARD

GB12 patents
⚠️ This page may combine multiple inventors who share the name “ASHTON MARK RICHARD”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

MIDDLEMISS DAVID

4 patents
US8314257B2Nov 20, 2012

Treatment of CRTH2-mediated diseases and conditions

MIDDLEMISS DAVID6 citations82
US8198314B2Jun 12, 2012

Treatment of CRTH2-mediated diseases and conditions

MIDDLEMISS DAVID7 citations82
US8163936B2Apr 24, 2012

Treatment of CRTH2-mediated diseases and conditions

MIDDLEMISS DAVID6 citations82
US8163931B2Apr 24, 2012

Treatment of CRTH2-mediated diseases and conditions

MIDDLEMISS DAVID6 citations82

ASTERAND UK LTD

2 patents
US7803841B2Sep 28, 2010

EP2 receptor agonists

ASTERAND UK LTD11 citations82
US7662839B2Feb 16, 2010

EP2 receptor agonists

ASTERAND UK LTD7 citations72

OXAGEN LTD

1 patent
US7582672B2Sep 1, 2009

Compounds for the treatment of CRTH2-mediated diseases and conditions

OXAGEN LTD32 citations95

PHARMAGENE LAB LTD

1 patent
US7326732B2Feb 5, 2008

EP2 receptor agonists

PHARMAGENE LAB LTD18 citations90

OXFORD ASYMMETRY INTERNAT PLC

1 patent
US6162951ADec 19, 2000

Phosphine ligands

OXFORD ASYMMETRY INTERNAT PLC10 citations64

OXFORD ALEXANDER WILLIAM

1 patent
US8080567B2Dec 20, 2011

EP2 receptor agonists

OXFORD ALEXANDER WILLIAM2 citations59

SYNGENTA PARTICIPATIONS AG

1 patent
US9686990B2Jun 27, 2017

Spiroindolinepiperidine derivatives

SYNGENTA PARTICIPATIONS AG0 citations48

HUGHES DAVID JOHN

1 patent
US9174987B2Nov 3, 2015

Spiroindolinepiperidine derivatives

HUGHES DAVID JOHN0 citations42